Neurocrine Biosciences, Inc. (0K6R.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:54PM GMT
| Previous close | 75.44 |
| Open | 73.05 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 73.05 - 74.92 |
| 52-week range | 73.05 - 74.92 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 9.021B |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 20.18 |
| EPS (TTM) | 4.54 |
| Earnings date | 02 Feb 2022 - 07 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Here's Why I Think Neurocrine Biosciences (NASDAQ:NBIX) Is An Interesting Stock
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
- Motley Fool
Why Neurocrine Biosciences Shares Fell Nearly 10% Today
Shares of biopharma Neurocrine Biosciences (NASDAQ: NBIX) were down 9.8% in Tuesday's late trading following a disappointing third-quarter report. For the three-month stretch ending in September, Neurocrine turned $296 million in revenue into an operating profit of $0.64 per share. On the basis of generally accepted accounting principles (GAAP), however, profits of only $0.23 per share left the market wanting more, and arguably concerned.
- Motley Fool
Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript
NBIX earnings call for the period ending September 30, 2021.
© 2022 Yahoo. All rights reserved.
